Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Scorsetti M, Leo F, Trama A, D’Angelillo R, Serpico D, Macerelli M, Zucali P, Gatta G, Garassino MC. Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 2016;99:332–50.
2. Hsu CH, Chan JK, Yin CH, Lee CC, Chern CU, Liao CI. Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States. PLoS One. 2019;14(12):e0227197.
3. Thymoma and Thymic Carcinoma Treatment (Adult) (PDQ®)–Health Professional Version. National Cancer Institute; 2019, October 1. Available from website: https://www.cancer.gov/types/thymoma/hp/thymoma-treatment-pdq
4. de Jong WK, Blaauwgeers JL, Schaapveld M, Timens W, Klinkenberg TJ, Groen HJ. Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer (Oxford, England: 1990). 2008;44:123–30.
5. Lucchi M, Ricciardi R, Melfi F, Duranti L, Basolo F, Palmiero G, et al. Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment. Eur J Cardio-thorac Surg: Off J Eur Assoc Cardio-thoracic Surg. 2009;35:812–6 (discussion 6).